Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers Sep. 3, 1999 No Comments
ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1 Sep. 1, 1999 No Comments
AGN-194310, a high-affinity RAR antagonist for treating retinoid-induced toxicities Sep. 1, 1999 No Comments
Ortec requests FDA permission to initiate CCS trial for diabetic ulcer therapy Aug. 31, 1999 No Comments
RSS